HALO Halozyme Therapeutics, Inc.: Multiplikator nilai perusahaan marang pendapatan

halozyme.com (HALO) - logo korporat

Halozyme Therapeutics (HALO) monetizes the ENHANZE method by converting intravenous drugs into subcutaneous injection formats. The EV/Sales trajectory demonstrates the impact of this strategy, with the current value standing at 7092.24. Growth is driven by royalties from blockbuster drugs and share buybacks. The licensing model ensures scalability with minimal costs, creating powerful operating leverage for capitalization.

HALO - Nilai perusahaan marang pendapatan Halozyme ing rentang 23.11.2025 - 20.11.2026

halozyme.com - rincian analitis lan metrik utama (HALO)

- rega saham lan prakiraan rega para ahli:
- indikator dhuwit lan arus kas:
Pambiji fundamental:Halozyme HALO
Produk asil prodhuksi Halozyme Therapeutics

Investors are assessing the resilience of Halozyme Therapeutics (HALO) through the lens of its ability to generate cash flow with minimal operational risks. Its monopoly position in the subcutaneous drug delivery segment and the receipt of royalties from industry behemoths ensure high revenue margins. This unlevered revenue-based valuation compares market capitalization with operating income, stripping out the impact of leverage to determine a fair multiple.

Pesaing langsung

Rasio nilai perusahaan marang dodolan BeiGene Ltd (ONC)|Revolution Medicines Corp (RVMD) - Rasio nilai perusahaan marang pendapatan|Multiplikator nilai perusahaan marang pendapatan Ascentage Pharma Group International (AAPG)|Rasio nilai perusahaan marang pendapatan CG Oncology, Inc.|Multiplikator nilai perusahaan marang pendapatan UroGen Pharma Corp URGN|Multiplikator EV/Sales BCAX|Personalis, Inc. - Rasio nilai perusahaan marang pendapatan|Erasca - Nilai perusahaan marang pendapatan|Nilai bisnis marang pendapatan DCTH|YMAB: Nilai perusahaan marang pendapatan|Multiplikator nilai perusahaan marang pendapatan Aura Corp|CADL: Multiplikator EV/Sales|ARAY - Rasio total nilai perusahaan marang pendapatan|SLS (SELLAS Life Sciences Group, Inc.) - Multiplikator EV/Sales|ACTU: Nilai bisnis marang pendapatan|Rasio nilai perusahaan marang pendapatan citiusonc.com (CTOR)|Rasio total nilai perusahaan marang pendapatan TuHURA Biosciences|Rasio nilai perusahaan marang pendapatan Protara Therapeutics TARA|Fate Therapeutics (FATE) - Multiplikator nilai perusahaan marang pendapatan|WHWK - Rasio nilai perusahaan marang pendapatan|Multiplikator nilai perusahaan marang pendapatan TScan Therapeutics Inc|championsoncology.com (CSBR) - Rasio nilai perusahaan marang pendapatan|Rasio nilai perusahaan marang pendapatan XBIT|Nilai perusahaan marang pendapatan CVM|Rasio nilai perusahaan marang pendapatan OSTX (OS Therapies Incorporated)|Multiplikator EV/Sales RADX|ARTV: Nilai perusahaan marang volume dodolan|Multiplikator EV/Sales ANL (Adlai Nortye Ltd)|VERU - Nilai perusahaan marang pendapatan|tempesttx.com - Multiplikator EV/Sales|Nilai bisnis marang pendapatan XLO (xiliotx.com)|RENB: Multiplikator EV/Sales|Nilai perusahaan marang pendapatan Mural Oncology plc|Rasio nilai perusahaan marang pendapatan Kairos Pharma Inc|OKUR: Nilai bisnis marang pendapatan|Multiplikator EV/Sales GDTC|CRIS (Curis) - Nilai bisnis marang pendapatan|Rasio nilai perusahaan marang pendapatan apollomicsinc.com APLM|THAR: Rasio nilai perusahaan marang pendapatan|advanbiomed.com - Multiplikator EV/Sales|Nilai bisnis marang pendapatan GNPX (Genprex, Inc)|Calidi Biotherapeutics Inc. (CLDI) - Rasio nilai perusahaan marang pendapatan|Sunshine Biopharma Inc. (SBFM) - Multiplikator EV/Sales|XBIO (Xenetic Bio) - Multiplikator EV/Sales|Salarius Pharmaceuticals Inc (SLRX) - Rasio total nilai perusahaan marang pendapatan|Multiplikator EV/Sales PPBT|Multiplikator EV/Sales American Oncology Network Inc (AONC)|Multiplikator EV/Sales BGNE (BeiGene Ltd.)|Koefisien nilai perusahaan marang pendapatan CKPT (Checkpoint Therapeutics)|ELEV - Rasio nilai perusahaan marang pendapatan|ICAD (iCAD Inc.) - Rasio nilai perusahaan marang pendapatan|Ikena (IKNA) - Rasio nilai perusahaan marang pendapatan|Nilai perusahaan marang pendapatan Notable Labs, Ltd.|Rasio nilai perusahaan marang pendapatan viracta.com|MOR: Nilai bisnis marang pendapatan|Multiplikator EV/Sales NAYA|Ascentage Pharma - Rasio nilai perusahaan marang pendapatan